Clinical Trials Directory

Trials / Unknown

UnknownNCT05358899

Accelerated cTBS on Metabolic Dysfunction in People With Schizophrenia

The Effect and Safety of Accelerated Continuous Theta-burst Stimulation on Metabolic Dysfunction in People With Schizophrenia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Central South University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

cTBS is a promising novel intervention, which has strong potential on moderating disease syndrome. However, the most effective pattern of the cTBS is still under debate. Therefore, the investigators designed this randomized controlled clinical trial to evaluate the efficacy and safety of accelerated cTBS, with 1800 stimulation per session, on intervention to metabolic side effects in individuals with schizophrenia.

Conditions

Interventions

TypeNameDescription
DEVICEaccelerated theta burst stimulationcTBS was administered at 80% of each participant's M1 area in a burst-firing pattern (3 pulses at 50 Hz) with a repetition frequency of 5 Hz (200 ms intervals). During each session, participants received 1800 pulses (120 s).
DEVICESham stimulationSimilar process with the accelerated theta burst stimulation with the coil 90 degrees tilted to the surface of the scalp, which could produce identical sound and vibration while avoiding real magnetic stimulation.

Timeline

Start date
2022-06-01
Primary completion
2022-12-01
Completion
2023-05-01
First posted
2022-05-03
Last updated
2022-11-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05358899. Inclusion in this directory is not an endorsement.